EUVIMEDEUVIMED entdecken
Open Access

Myofibroblastic cancer‐associated fibroblast subtype heterogeneity in pancreatic cancer

Joseph F Kearney, Hannah E Trembath, Priscilla S Chan, Ashley B Morrison, Yi Xu, Chang Fei Luan, Ian C McCabe, Sandra A Zarmer, Hong Jin Kim, Xianlu L Peng, Jen Jen Yeh

Journal of Surgical Oncology · 2024-04 · 129 (5) · 860-868

DOI: 10.1002/jso.27582 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 17.01.2024. Verfasst von Joseph F Kearney und 10 weiteren Autor:innen. Beteiligte Einrichtung: The University of North Carolina at Chapel Hill Department of Surgery, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic ductal adenocarcinoma (PDAC) has a fibrotic stroma that has both tumor‐promoting and tumor‐restraining properties. Different types of cancer‐associated fibroblasts (CAFs) have been described. Here, we investigated whether CAFs within the same subtype exhibit heterogeneous functions.

Methods

We evaluated the gene and protein expression differences in two myofibroblastic CAF (myCAF) lines using single‐cell and bulk RNA‐sequencing. We utilized proliferation and migration assays to determine the effect of different CAF lines on a tumor cell line.

Results

We found that myCAF lines express an activated stroma subtype gene signature, which is associated with a shorter survival in patients. Although both myCAF lines expressed α‐smooth muscle actin (α‐SMA), platelet‐derived growth factor‐α (PDGFR‐α), fibroblast‐activated protein (FAP), and vimentin, we observed heterogeneity between the two lines. Similarly, despite being consistent with myCAF gene expression overall, heterogeneity within specific genes was observed. We found that these differences extended to the functional level where the two myCAF lines had different effects on the same tumor cell line. The myCAF216 line, which had slightly increased inflammatory CAF‐like gene expression and higher protein expression of α‐SMA, PDGFR‐α, and FAP was found to restrain migration of tumor cells.

Conclusions

We found that two myCAF lines with globally similar expression characteristics had different effects on the same tumor cell line, one promoting and the other restraining migration. Our study highlights that there may be unappreciated heterogeneity within CAF subtypes. Further investigation and attention to specific genes or proteins that may drive this heterogeneity will be important.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer-Associated FibroblastsPancreatic NeoplasmsCarcinoma, Pancreatic DuctalHumansFibroblastsCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

cancer‐associated fibroblastspancreatic adenocarcinomatumor microenvironment

Autor:innen und Institutionen

  • The University of North Carolina at Chapel Hill Department of Surgery, Chapel Hill, North Carolina, USA.
  • The University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.

Förderung

  • NCI NIH HHS

Zitieren

APA

Kearney, J. F., Trembath, H. E., Chan, P. S., Morrison, A. B., Xu, Y., Luan, C. F., McCabe, I. C., Zarmer, S. A., Kim, H. J., Peng, X. L., & Yeh, J. J. (2024). Myofibroblastic cancer‐associated fibroblast subtype heterogeneity in pancreatic cancer. Journal of Surgical Oncology, 129(5), 860-868. https://doi.org/10.1002/jso.27582

Vancouver

Kearney JF, Trembath HE, Chan PS, Morrison AB, Xu Y, Luan CF, et al. Myofibroblastic cancer‐associated fibroblast subtype heterogeneity in pancreatic cancer. Journal of Surgical Oncology. 2024;129(5):860-868. doi:10.1002/jso.27582

BibTeX
@article{Kearney2024,
  author = {Kearney, Joseph F and Trembath, Hannah E and Chan, Priscilla S and Morrison, Ashley B and Xu, Yi and Luan, Chang Fei and McCabe, Ian C and Zarmer, Sandra A and Kim, Hong Jin and Peng, Xianlu L and Yeh, Jen Jen},
  title = {Myofibroblastic cancer‐associated fibroblast subtype heterogeneity in pancreatic cancer},
  journal = {Journal of Surgical Oncology},
  year = {2024},
  volume = {129},
  number = {5},
  pages = {860--868},
  doi = {10.1002/jso.27582}
}
Kostenlos starten →